The linked FDA records identify DePuy Orthopaedics, Inc. at 700 Orthopaedic Dr., Warsaw, Indiana, as the applicant on three linked device filings: one 510(k) clearance and two PMA actions. The records cover two distinct product lines, a revision knee system and a ceramic hip system, and span decision dates from 2010 to 2026. The collection is a snapshot of the supplied filings, not a measure of total portfolio, sales or safety performance. [1][2][3]
ATTUNE Revision Knee System clearance
K262130 covers the ATTUNE Revision Knee System under 21 CFR 888.3560, the regulation for a knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis, Class II, product codes JWH and MBH. The submission was received June 24, 2026, reviewed by the Orthopedic advisory committee, and decided September 4, 2026 as Substantially Equivalent under a Traditional clearance with a summary available. [1][4]
The FDA database entry lists the applicant as Depuy Orthopaedics, Inc. with a Warsaw, Indiana address and names Christina Kaucic as contact. The clearance letter is addressed to Christina Kaucic, Project Lead, Regulatory Affairs, at the same Warsaw address. [1][4]
CERAMAX Ceramic Hip System approvals
P070026 approved the CERAMAX Ceramic Total Hip System on December 23, 2010, with a Federal Register notice date of January 25, 2011. The approval statement describes noncemented use in skeletally mature individuals undergoing primary total hip replacement for rehabilitation of hips damaged by noninflammatory degenerative joint disease or its composite diagnoses of osteoarthritis, avascular necrosis and post-traumatic arthritis. The device is a Class III semi-constrained metal/ceramic/ceramic/metal hip prosthesis under product code MRA. [3]
Supplement P070026/S129 was received August 5, 2026 and decided September 4, 2026 as a 30-Day Notice. Its stated reason is a process change affecting manufacturer, sterilizer, packager or supplier, and the applicant order statement describes the addition of an alternate component forging supplier for business continuity purposes. [2]
How the supplied collection is composed
The linked collection contains three records: one 510(k) and two PMA actions. Decision counts across the full collection are one Substantially Equivalent, one 30-Day Notice and one Approval. The explicitly smaller record sample of three rows carries the same three decisions, so the two denominators are not interchangeable and neither supports a broader portfolio ratio. [1][2][3]
No recall records appear in the supplied sample. That absence reflects the MedtechLedger snapshot only and does not establish recall history or safety performance for either product line. [1][2][3]
Applicant identity and related documentation
The knee system also appears in a July 11, 2024 clearance letter to DePuy Ireland UC for K241000, which lists the ATTUNE Revision Knee System alongside DePuy Knee Prosthesis System Universal Stem Extensions and Universal Femoral Metaphyseal Sleeves, DePuy Sigma PS Femoral Components, DePuy Sigma Cruciate Retaining Porocoat Femoral Components and the S-ROM NOILES Rotating Hinge Knee System. That letter names DePuy Orthopaedics, Inc. as correspondent at 700 Orthopaedic Drive, Warsaw, Indiana. [9]
A DePuy Synthes product reference guide for the ATTUNE Revision Knee System lists fixed bearing and rotating platform implants, including femoral components and tibial inserts, and carries DePuy Orthopaedics, Inc. contact details at 700 Orthopaedic Drive, Warsaw, Indiana. The guide is marked for internal use only, so it documents product naming and component categories rather than commercial availability. [10]
